Department of General Pediatrics, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.
Clinical Research Support Center, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.
J Pediatr. 2022 Jan;240:158-163.e4. doi: 10.1016/j.jpeds.2021.08.065. Epub 2021 Aug 27.
To detect risk factors of coronary artery aneurysm (CAA) development in patients with Kawasaki disease determined to have a low risk for resistance to primary intravenous immunoglobulin (IVIG) treatment based on the Kobayashi score.
This study included 1757 predicted IVIG responders from Prospective Observational study on STRAtified treatment with Immunoglobulin plus Steroid Efficacy for Kawasaki disease (Post RAISE), a large-scale, multicenter, prospective cohort study of Kawasaki disease in Japan. Predicted IVIG responders were defined as patients with Kawasaki disease with a Kobayashi score of <5, a predictive scoring system for IVIG resistance created in Japan. The primary outcome was CAA development at 1 month after disease onset. CAA was defined as a Z score of ≥2.5. Multivariable logistic regression was used to identify the independent risk factors of CAA. The variables for inclusion were identified based on univariate analysis results and previously reported risk factors of CAA.
Among 1632 patients who had complete coronary outcome data, CAA developed in 90 patients (5.5%) at 1 month after disease onset. Multivariable analysis found that a baseline maximum Z score of >2.5, age of <12 months at fever onset, and nonresponsiveness to IVIG were significant, independent risk factors of CAA development at 1 month after disease onset. Among the risk factors, a baseline maximum Z score of >2.5 was most strongly associated with CAA development (OR, 7.1; 95% CI, 4.1-12.2; P ≤ .001).
Predicted IVIG responders with CAA risk factors identified in this study may be candidates for future clinical trials of intensified primary IVIG treatment with prednisolone, cyclosporine or infliximab.
根据小林评分,检测川崎病(KD)患者对静脉注射免疫球蛋白(IVIG)治疗原发性耐药低危人群发生冠状动脉瘤(CAA)的危险因素。
本研究纳入了日本前瞻性观察性分层治疗研究(Post RAISE)中 1757 例预测 IVIG 有效患者,该研究为一项大规模、多中心、前瞻性队列研究。预测 IVIG 有效者被定义为小林评分<5 的川崎病患者,小林评分是日本创建的预测 IVIG 耐药的预测评分系统。主要结局为发病后 1 个月时 CAA 的发生。CAA 定义为 Z 评分≥2.5。采用多变量逻辑回归确定 CAA 的独立危险因素。纳入的变量基于单变量分析结果和先前报道的 CAA 危险因素。
在 1632 例具有完整冠状动脉结局数据的患者中,90 例(5.5%)患者在发病后 1 个月时发生 CAA。多变量分析发现,基线最大 Z 评分>2.5、发热开始时年龄<12 个月和 IVIG 无反应是发病后 1 个月时 CAA 发生的独立危险因素。在这些危险因素中,基线最大 Z 评分>2.5 与 CAA 发生的相关性最强(OR,7.1;95%CI,4.1-12.2;P≤0.001)。
本研究确定了预测 IVIG 有效患者的 CAA 危险因素,这些患者可能是未来强化 IVIG 治疗加用泼尼松龙、环孢素或英夫利昔单抗的临床试验的候选者。